Dose-related effects of recombinant human erythropoietin on erythropoiesis. Results of a multicenter trial in patients with end-stage renal disease.

J. Bömmer(Heidelberg University), P. Scigalla, P. Bramsiepe(University of Cologne), Markus Kügel(Heidelberg University), R. Brunkhorst(Medizinische Hochschule Hannover), W. Schoeppe(Unknown), W. Samtleben(Ludwig-Maximilians-Universität München)
PubMed
January 1, 1988
Cited by 55

Related Papers

Bone histology in incipient and advanced renal failure
|Kidney International|1976|314
Serum erythropoietin concentration in chronic renal failure: relationship to degree of anemia and excretory renal function
|Blood|1979|215
Circulating adrenomedullin estimates survival and reversibility of organ failure in sepsis: the prospective observational multinational Adrenomedullin and Outcome in Sepsis and Septic Shock-1 (AdrenOSS-1) study
|Critical Care|2018|134
Age-related glomerulosclerosis and interstitial fibrosis in Milan normotensive rats: A podocyte disease
|Kidney International|1997|133
Elevated levels of soluble CD 14 in serum of patients with systemic lupus erythematosus
|Clinical & Experimental Immunology|1994|115